Autori: Szarek Michael
Naslov | Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial (Article) |
Autori | Szarek Michael ... Dilic Mirza ... Ristic Arsen D ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, (2019), vol. 12 br. 11, str. - |
Projekat | Fondation Assistance Publique-Hopitaux de Paris, Paris, France |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial (Article) |
Autori | Szarek Michael ... Dilic Mirza ... Ristic Arsen D ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, (2019), vol. 73 br. 4, str. 387-396 |
Projekat | Sanofi-Aventis; Regeneron Pharmaceuticals, Inc.; Fondation Assistance Publique-Hopitaux de Paris |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|